rs375654005
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The NM_000183.3(HADHB):c.686G>A(p.Arg229Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,650 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000183.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HADHB | NM_000183.3 | c.686G>A | p.Arg229Gln | missense_variant | 9/16 | ENST00000317799.10 | NP_000174.1 | |
HADHB | NM_001281512.2 | c.641G>A | p.Arg214Gln | missense_variant | 8/15 | NP_001268441.1 | ||
HADHB | NM_001281513.2 | c.620G>A | p.Arg207Gln | missense_variant | 10/17 | NP_001268442.1 | ||
HADHB | XM_011532803.2 | c.686G>A | p.Arg229Gln | missense_variant | 9/16 | XP_011531105.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HADHB | ENST00000317799.10 | c.686G>A | p.Arg229Gln | missense_variant | 9/16 | 1 | NM_000183.3 | ENSP00000325136.5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251326Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135832
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461650Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 727144
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Mitochondrial trifunctional protein deficiency 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Nov 28, 2023 | - - |
Mitochondrial trifunctional protein deficiency 2 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 24, 2024 | - - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 02, 2019 | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 30990523) - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 24, 2024 | Variant summary: HADHB c.686G>A (p.Arg229Gln) results in a conservative amino acid change located in the Thiolase, N-terminal (IPR020616) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251326 control chromosomes (gnomAD). c.686G>A has been reported in the literature in individuals affected with features of Mitochondrial Trifunctional Protein Deficiency (Madsen_2019, Guan_2021). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 30990523, 34712195). ClinVar contains an entry for this variant (Variation ID: 429516). Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at